N914UP

The airframe bearing registration N914UP is a Boeing 767-300F built in 2025 (manufacturer: The Boeing Company), serial number 67983. The aircraft is recorded as owned by BOEING CO (type: corporation) located in Renton, WA, US, and is registered in the US. As a newly built freighter into the mid-2020s fleet, this airframe presents the characteristics of a factory-produced, main-deck cargo conversion/role with a two-crew flightdeck; it is delivered into corporate ownership in the manufacturer's hometown region. No other ownership transfers or registry events are recorded in the provided data.

The aircraft is outfitted in a main-deck freighter (cargo) configuration with a flightdeck crew of 2, reflecting its primary role as a single-aisle widebody freighter optimized for trunk cargo operations. Typical mission profiles for this configuration include medium- to long-range freight sectors within a roughly 3,225 nm radius at a cruise speed near 460 kts, exploiting the airframe’s payload-to-range capability. Based in Renton, WA, US under ownership by BOEING CO, the airframe would follow factory maintenance planning and Boeing-recommended inspection cycles; its freighter cabin and main-deck arrangements impose specific maintenance and logistics considerations related to cargo handling systems, floor strength and large-door operations. Avionics fit and operator-specific equipment are not published in the supplied data.

The Boeing 767-300F occupies a niche as a medium widebody freighter that balances payload capacity and range for transcontinental and near-intercontinental cargo routes. Powered by twin GE CF6-80C2B6F engines producing 60,030 lbf each, this variant competes with other twin-aisle freighters in the same class and with newer converted narrowbodies for certain regional markets. Buyer demand typically centers on cargo operators needing main-deck volume and efficient twin-engine economics; resale and maintenance considerations hinge on airframe cycles, freighter-specific structural inspections, and engine-life management consistent with the CF6 family.